Cardiac events occuring in 11 of 77 patients
| Patient | Sex | Age at first event (years) | CTG code | Time to event (years) | Event |
| 1 | M | 62 | E1 | 6.0 | CAA |
| 2 | F | 41 | E2 | Baseline | CAA |
| 3 | M | 18 | E2 | Baseline | CAA |
| 4 | M | 25 | E2 | Baseline | CAA |
| 5 | F | 58 | E2 | 1.3 | PPM |
| 6 | M | 67 | E2 | 3.1 | CAA |
| 7 | F | 54 | E2 | 4.6 | PPM |
| 8 | F | 36 | E2 | 4.0 | CAA |
| 5.4 | PPM | ||||
| 9 | M | 44 | E3 | Baseline | CAA, PPM |
| 10 | F | 34 | E3 | Baseline | PAF |
| 4.1 | VT | ||||
| 5.4 | SCD | ||||
| 11 | M | 28 | E3 | 0.3 | PPM |
| 9.1 | VT | ||||
| 9.3 | SCD |
CAA, chronic atrial arrhythmia; PPM, permanent pacemaker; SCD, sudden or arrhythmic cardiac death; VT, ventricular tachycardia. Those with atrial arrhythmias at baseline (patients 2, 3, 4, and 9) were excluded from the analysis of conduction disease progression.